التفاصيل البيبلوغرافية
| العنوان: |
Acalabrutinib With Obinutuzumab in Treatment-Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia: 3-Year Follow-Up |
| المؤلفون: |
C. Quah, M.H. Wang, Jennifer A. Woyach, Ahmed Hamdy, V. Munugalavadla, Seema A. Bhat, James S. Blachly, M.M. Frigault, John C. Byrd, R. Izumi, Mojgan Jianfar, Kerry A. Rogers |
| المصدر: |
Hematological Oncology. 37:209-210 |
| بيانات النشر: |
Wiley, 2019. |
| سنة النشر: |
2019 |
| مصطلحات موضوعية: |
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Chronic lymphocytic leukemia, Hematology, General Medicine, medicine.disease, Therapy naive, chemistry.chemical_compound, chemistry, Obinutuzumab, Internal medicine, Relapsed refractory, medicine, Acalabrutinib, business |
| تدمد: |
0278-0232 |
| DOI: |
10.1002/hon.26_2630 |
| URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_________::5ebdc618bcce56bf61a6cc6602746882
https://doi.org/10.1002/hon.26_2630 |
| Rights: |
CLOSED |
| رقم الانضمام: |
edsair.doi...........5ebdc618bcce56bf61a6cc6602746882 |
| قاعدة البيانات: |
OpenAIRE |